//Faster Path to Clinical Approval

From flexible research tools to statistical regulatory-grade clinical analytics, without losing agility.

ASSESS YOUR CLINICAL ANALYTICS READINESS

// Faster Path to Clinical Approval

From flexible research tools to controlled and validated statistical compute environment. Regulatory-grade clinical analytics, without losing agility.

start your sas viya assessment

// Your data environment must evolve as you enter clinical phases

Early research environments are built for flexibility. Clinical environments must be built for reproducibility, traceability, and compliance.

// Flexibility alone is not enough for submission

Full traceability of transformations
Reproducible and auditable workflows
Structural Clinical Data Repository
Controlled and validated compute environment

The most successful biotech teams combine innovation tools with a governed analytics backbone.

SEE HOW IT WORKS

// Every month to market matters

Drug development takes long. Patent protection if finite.
Faster statistical analytics directly increase commercial runaway.

Parallel processing for faster outputs
Accelerated TLF generation
Reduced rework and validation cycles
Scalable environment for growing trials

// Clinical Analytics Readiness Assessment

We help growing biotech organizations evaluate whether their current data and statistical analytics environment is ready for regulatory scale.

What the assessment covers:

Current tool landscape
Regulatory exposure
Data architecture maturity
CDR & SCE roadmap
Practical next steps

Michael Gomes is Resell Director at Notiyze and Member of the SAS Partner Advisory Board. With an extended knowledge in sales, consulting management and project delivery in the areas of Data Management, Clinical Research, BI & Analytics, Michael counts with more than 20 years within the life sciences industry.

schedule a consultation with michael

// Contact

Notilyze B.V.
Stationsplein 45 A4.004
3013 AK Rotterdam
+31 (0)10 79 86 295
info@notilyze.com